SPA
GH icon

Sherbrooke Park Advisers’s Guardant Health GH Stock Holding History

Sherbrooke Park Advisers’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,134
Closed -$248K – 730
2024
Q4 		$248K Buy
+8,134
New +$229K 0.08% 485
2023
Q1 		– Sell
-18,100
Closed -$492K – 235
2022
Q4 		$492K Buy
+18,100
New +$828K 0.36% 123

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sherbrooke Park Advisers's GH Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Guardant Health (GH) in Q1 2025, closing a stake of 8,134 shares — an estimated $248K sold.

Sherbrooke Park Advisers first reported a position in GH in Q4 2022 and held it in 2 quarters. The position peaked at $492K in Q4 2022. 341 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 8,134 Guardant Health shares in Q1 2025, an estimated $248K.
  • Sherbrooke Park Advisers first reported a position in Guardant Health in Q4 2022 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Guardant Health position peaked at $492K in Q4 2022.
  • 341 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.